Advertisement

Mesenteric fat cryolipolysis attenuates insulin resistance in the Ossabaw swine model of the metabolic syndrome

Published:October 27, 2022DOI:https://doi.org/10.1016/j.soard.2022.10.023

      Abstract

      Background

      The rising prevalence of insulin resistance (IR), metabolic syndrome, and type 2 diabetes are associated with increases in abdominal mesenteric fat. Adipocytes are sensitive to low temperatures, making cryolipolysis of mesenteric fat an attractive treatment modality to potentially reduce IR.

      Objectives

      We aimed to determine whether (1) cryolipolysis is safe in reducing the volume of the mesenteric fat and (2) reduction in mesenteric fat volume reduces indices of IR and glycemic dysfunction.

      Setting

      Indiana University School of Medicine.

      Methods

      A novel cooling device and method delivered cryolipolysis in a controlled manner to avoid tissue ablative temperatures. Ossabaw pigs (n = 8) were fed a high-fat diet for 9 months to develop visceral obesity, IR, and metabolic syndrome. Following laparotomy, mesenteric fat cryolipolysis (MFC) was performed in 5 pigs, while 3 served as sham surgery controls. The volume of the mesenteric fat was measured by computed tomography and compared with indices of glucose intolerance before and at 3 and 6 months postprocedure.

      Results

      MFC safely reduced mesenteric fat volume by ∼30% at 3 months, which was maintained at 6 months. Body weight did not change in either the MFC or sham surgery control groups. Measure of glycemic control, insulin sensitivity, and blood pressure significantly improved after MFC compared with sham controls.

      Conclusion

      MFC reduces the volume of mesenteric fat and improves glycemic control in obese, IR Ossabaw pigs, without adverse effects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bhupathiraju S.N.
        • Hu F.B.
        Epidemiology of obesity and diabetes and their cardiovascular complications.
        Circ Res. 2016; 118: 1723-1735
        • Hardy O.T.
        • Czech M.P.
        • Corvera S.
        What causes the insulin resistance underlying obesity?.
        Curr Opin Endocrinol Diabetes Obes. 2012; 19: 81-87
        • Barzilai N.
        • She L.
        • Liu B.Q.
        • et al.
        Surgical removal of visceral fat reverses hepatic insulin resistance.
        Diabetes. 1999; 48: 94-98
        • Gabriely I.
        • Ma X.H.
        • Yang X.M.
        • et al.
        Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?.
        Diabetes. 2002; 51: 2951-2958
        • Kabir M.
        • Catalano K.J.
        • Ananthnarayan S.
        • et al.
        Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
        Am J Physiol Endocrinol Metab. 2005; 288: e454-e461
        • Andrew M.S.
        • Huffman D.M.
        • Rodriguez-Ayala E.
        • Williams N.N.
        • Peterson R.M.
        • Bastarrachea R.A.
        Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons.
        Surg Obes Relat Dis. 2018 Jun; 14: 833-841
        • Yang Y.K.
        • Chen M.
        • Clements R.H.
        • Abrams G.A.
        • Aprahamian C.J.
        • Harmon C.M.
        Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes.
        Cell Physiol Biochem. 2008; 22: 531-538
        • Wueest S.
        • Item F.
        • Lucchini F.C.
        • et al.
        Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance.
        Diabetes. 2016; 65: 140-148
        • Liu K.H.
        • Chan Y.L.
        • Chan W.B.
        • Chan J.C.N.
        • Chu C.W.W.
        Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness.
        Diabetes Care. 2006; 29: 379-384
      1. Expert Panel on Detection E and Treatment of High Blook Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Klein S.
        The case of visceral fat: argument for the defense.
        J Clin Invest. 2004; 113: 1530-1532
        • Thörne A.
        • Lönnqvist F.
        • Apelman J.
        • Hellers G.
        • Arner P.
        A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding.
        Int J Obes Relat Metab Disord. 2002; 26: 193-199
        • Csendes A.
        • Maluenda F.
        • Burgos A.M.
        A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy.
        Obes Surg. 2009; 19: 490-494
        • Dillard T.H.
        • Purnell J.Q.
        • Smith M.D.
        • et al.
        Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial.
        Surg Obes Relat Dis. 2013; 9: 269-275
        • Fabbrini E.
        • Tamboli R.A.
        • Magkos F.
        • et al.
        Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.
        Gastroenterology. 2010; 139: 448-455
        • Herrera M.F.
        • Pantoja J.P.
        • Velázquez-Fernández D.
        • et al.
        Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial.
        Diabetes Care. 2010; 33: 1413-1418
        • Neeland I.J.
        • Grundy S.M.
        • Li X.
        • Adams-Huet B.
        • Vega G.L.
        Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study.
        Nutr Diabetes. 2016; 6: e221
        • Salman A.A.
        • Salman M.A.
        • Said M.
        • et al.
        Improvement of pancreatic steatosis and indices of insulin resistance after metabolic surgery.
        Front Med (Lausanne). 2022; 9894465
        • Manstein D.
        • Laubach H.
        • Watanabe K.
        • Farinelli W.
        • Zurakowski D.
        • Anderson R.R.
        Selective cryolysis: a novel method of non-invasive fat removal.
        Lasers Surg Med. 2008; 40: 595-604
        • Coleman S.R.
        • Sachdeva K.
        • Egbert B.M.
        • Preciado J.
        • Allison J.
        Clinical efficacy of noninvasive cryolipolysis and its effects on peripheral nerves.
        Aesthetic Plast Surg. 2009; 33: 482-488
        • Derrick C.D.
        • Shridharani S.M.
        • Broyles J.M.
        the safety and efficacy of cryolipolysis: a systematic review of available literature.
        Aesthet Surg J. 2015; 35: 830-836
        • Ingargiola M.J.
        • Motakef S.
        • Chung M.T.
        • Vasconez H.C.
        • Sasaki G.H.
        Cryolipolysis for fat reduction and body contouring: safety and efficacy of current treatment paradigms.
        Plastic Reconstr Surg. 2015; 135: 1581-1590
        • Hall K.D.
        • Kahan S.
        Maintenance of lost weight and long-term management of obesity.
        Med Clin North Am. 2018; 102: 183-197
        • Sturek M.
        • Tune J.D.A.M.
        Ossabaw Island miniature swine: metabolic syndrome and cardiovascular assessment.
        in: Swindle M.M. Smith A.C. Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques. CRC Press, Boca Raton (FL)2015: 451-465
        • Sham J.G.
        • Simianu V.V.
        • Wright A.S.
        • et al.
        Evaluating the mechanisms of improved glucose homeostasis after bariatric surgery in Ossabaw miniature swine.
        J Diabetes Res. 2014; 2014526972
        • Neeb Z.P.
        • Edwards J.M.
        • Alloosh M.
        • Long X.
        • Mokelke E.A.
        • Sturek M.
        Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine.
        Comp Med. 2010; 60: 300-315
        • Cluzel G.L.
        • Ryan P.M.
        • Herisson F.M.
        • Caplice N.M.
        High-fidelity porcine models of metabolic syndrome: a contemporary synthesis.
        Am J Physiol Endocrinol Metab. 2022; 322: E366-E381
        • Sturek M.
        • Alloosh M.
        • Sellke F.W.
        Swine disease models for optimal vascular engineering.
        Annu Rev Biomed Eng. 2020; 22: 25-49
      2. National Research Council, Division on Earth and Life Studies, Institute for Laboratory Animal Research. Guide for the care and use of laboratory animals. 8th ed. Washington, D.C.: National Academies Press; 2011.

        • AVMA Panel on Euthanasia, American Veterinary Medical Association
        2000 Report of the AVMA Panel on Euthanasia.
        J Am Vet Med Assoc. 2001; 218: 669-696
        • McKenney M.L.
        • Schultz K.A.
        • Boyd J.H.
        • et al.
        Epicardial adipose excision slows the progression of porcine coronary atherosclerosis.
        J Cardiothorac Surg. 2014; 9: 2
        • Sasaki G.H.
        • Abelev N.
        • Tevez-Ortiz A.
        Noninvasive selective cryolipolysis and reperfusion recovery for localized natural fat reduction and contouring.
        Aesthet Surg J. 2014; 34: 420-431
        • Dyson M.C.
        • Alloosh M.
        • Vuchetich J.P.
        • Mokelke E.A.
        • Sturek M.
        Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet.
        Comp Med. 2006; 56: 35-45
        • Chang J.
        • Jung J.
        • Lee H.
        • Chang D.
        • Yoon J.
        • Choi M.
        Computed tomographic evaluation of abdominal fat in minipigs.
        J Vet Sci. 2011; 12: 91-94
        • Carroll J.A.
        • Daniel J.A.
        • Keisler D.H.
        • Matteri R.L.
        Non-surgical catheterization of the jugular vein in young pigs.
        Lab Anim. 1999; 33: 129-134
        • Stern S.E.W.K.
        • Ferrannini E.
        • DeFronzo R.A.
        • Bogardus C.
        • Stern M.P.
        Identification of individuals with insulin resistance using routine clinical measurements.
        Diabetes. 2005; 54: 333-339
        • Katz A.
        • Nambi S.S.
        • Mather K.
        • et al.
        Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.
        J Clin Endocrinol Metab. 2000; 85: 2402-2410
        • Klein S.
        • Gastaldelli A.
        • Yki-Järvinen H.
        • Scherer P.E.
        Why does obesity cause diabetes?.
        Cell Metab. 2022; 24: 11-20
        • Fruh S.M.
        Obesity: risk factors, complications, and strategies for sustainable long-term weight management.
        J Am Assoc Nurse Pract. 2017; 29: S3-S14
        • Després J.P.
        • Lemieux I.
        Abdominal obesity and metabolic syndrome.
        Nature. 2006; 444: 881-887
        • Lebovitz H.E.
        • Banerji M.A.
        Point: visceral adiposity is causally related to insulin resistance.
        Diabetes Care. 2005; 28: 2322-2325
        • Neeland I.J.
        • Ross R.
        • Després J.P.
        • et al.
        Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.
        Lancet Diabetes Endocrinol. 2019; 7: 715-725
        • Sironi A.M.
        • Gastaldelli A.
        • Mari A.
        • et al.
        Visceral fat in hypertension: influence on insulin resistance and beta-cell function.
        Hypertension. 2004; 44: 127-133
        • Cao E.
        • Watt M.J.
        • Nowell C.J.
        • et al.
        Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity.
        Nat Metab. 2021; 3: 1175-1188
        • Gálvez B.
        • de Castro J.
        • Herold D.
        • et al.
        Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1297-1302
        • Poetsch M.S.
        • Strano A.
        • Guan K.
        Role of leptin in cardiovascular diseases.
        Front Endocrinol (Lausanne). 2020; 11: 354
        • Zamami Y.
        • Takatori S.
        • Hobara N.
        • et al.
        Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries.
        Hypertens Res. 2011; 34: 1190-1196
        • Aloudah N.M.
        • Scott N.W.
        • Aljadhey H.S.
        • Araujo-Soares V.
        • Alrubeaan K.A.
        • Watson M.C.
        Medication adherence among patients with type 2 diabetes: a mixed methods study.
        PLoS One. 2018; 13e207583
        • Lee C.S.
        • Tan J.H.M.
        • Sankari U.
        • Koh Y.L.E.
        • Tan N.C.
        Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study.
        BMJ Open. 2017; 7e016317
        • Kim Y.Y.
        • Lee J.S.
        • Kang H.J.
        • Park S.M.
        Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.
        Sci Rep. 2018; 812190